Reneo Pharmaceuticals executive buys shares worth over 144k

RPHMDelisted Stock  USD 18.20  1.40  8.33%   
About 55% of RPHM Old's investors are presently thinking to get in. The analysis of current outlook of investing in RPHM Old suggests that some traders are interested regarding RPHM Old's prospects. RPHM Old's investing sentiment overview a quick insight into current market opportunities from investing in RPHM Old. Many technical investors use RPHM Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Reneo Pharmaceuticals executive buys shares worth over 144k

Read at investing.com
Investing News at Macroaxis
  

RPHM Old Fundamental Analysis

We analyze RPHM Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RPHM Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RPHM Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

RPHM Old is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

RPHM Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RPHM Old stock to make a market-neutral strategy. Peer analysis of RPHM Old could also be used in its relative valuation, which is a method of valuing RPHM Old by comparing valuation metrics with similar companies.

Peers

RPHM Old Related Equities

OCEAOcean Biomedical   7.25   
0%
87.0%
SMMTSummit Therapeutics   3.95   
0%
47.0%
KRONKronos Bio   3.09   
0%
37.0%
KZRKezar Life   3.01   
0%
36.0%
RPRXRoyalty Pharma   1.13   
0%
13.0%
CELCCelcuity LLC   0.91   
0%
10.0%
APLSApellis Pharmaceuticals   0.73   
0%
8.0%
ADPTAdaptive Biotechnologies   0.71   
0%
8.0%
PRMEPrime Medicine,   0.31   
0%
3.0%
VIRVir Biotechnology   0.75   
9.0%
0%
IMMXImmix Biopharma   0.87   
10.0%
0%
NKTXNkarta   1.63   
19.0%
0%
CGEMCullinan Oncology   1.87   
22.0%
0%
LEGNLegend Biotech   3.34   
40.0%
0%
DNAGinkgo Bioworks   3.86   
46.0%
0%
HOWLWerewolf Therapeutics   4.32   
51.0%
0%
EWTXEdgewise Therapeutics   4.37   
52.0%
0%
CCCCC4 Therapeutics   5.62   
67.0%
0%
HEPAHepion Pharmaceuticals   6.15   
73.0%
0%
CNSPCns Pharmaceuticals   8.33   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in RPHM Stock

If you are still planning to invest in RPHM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RPHM Old's history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance